| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Lin,Yu-Xin | Chairman | 8.26% | Lin Scientific Inc. |
| Wang,Zheng-Qi | Director | 0.66% | |
| Wang,Hui-Jun | Independent Director | 0.00% | |
| Tu,San-Qian | Independent Director | 0.00% | |
| Liang,Wei-Ren | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | - | - | - |
| Operating cost | - | - | - |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | - | - | - |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | - | - | - |
| Operating expenses | 635,336 | 1,096,827 | 445,129 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -635,336 | -1,096,827 | -445,129 |
| Non-operating income and expenses | 50,993 | 6,285 | -32,744 |
| Net profit (loss) before tax | -584,343 | -1,090,542 | -477,873 |
| Income tax expense (benefits) | 188 | -29,724 | -18,439 |
| Net profit (loss) of ongoing business for the current period | -584,531 | -1,060,818 | -459,434 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -584,531 | -1,060,818 | -459,434 |
| Other comprehensive profit (loss), net | 159,107 | -10,131 | 78,682 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -425,424 | -1,070,949 | -380,752 |
| Net profit (loss) attributable to owners of parent company | -346,829 | -687,190 | -313,524 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -237,702 | -373,628 | -145,910 |
| Comprehensive profit (loss) attributable to owners of parent company | -254,161 | -699,969 | -244,242 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -171,263 | -370,980 | -136,510 |
| Basic earnings per share (yuan) | -4 | -9 | -4 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -574,815 | -1,012,818 | -361,014 |
| Net cash inflows (outflows) from investing activities | -2,920,247 | 1,866 | -24,055 |
| Net cash inflow (outflow) from financing activities | 1,285,412 | 2,636,911 | 1,129,793 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 151,607 | -10,137 | 93,663 |
| Increase (decrease) in cash and cash equivalents in the current period | -2,058,043 | 1,615,822 | 838,387 |
| Beginning balance of cash and cash equivalents | 3,261,057 | 1,645,235 | 806,848 |
| Ending balance of cash and cash equivalents | 1,203,014 | 3,261,057 | 1,645,235 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 4,331,133 | 3,424,216 | 1,672,358 |
| Non-current asset | 175,459 | 172,506 | 179,719 |
| Total asset | 4,506,592 | 3,596,722 | 1,852,077 |
| Current liability | 131,426 | 138,704 | 79,876 |
| Non-current liability | 22,534 | 29,026 | 36,180 |
| Total liability | 153,960 | 167,730 | 116,056 |
| share capital | 786,298 | 785,560 | 724,010 |
| Equity - secruity token | - | - | - |
| capital reserve | 4,132,927 | 3,477,220 | 1,934,575 |
| retained earning | -2,509,167 | -2,162,338 | -1,475,148 |
| Other equity | 129,238 | 36,942 | 50,724 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 2,539,296 | 2,137,384 | 1,234,161 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 1,813,336 | 1,291,608 | 501,860 |
| Total Equity | 4,352,632 | 3,428,992 | 1,736,021 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 40,000 | 82,200 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 32 | 27 | 17 |
